Full text
Earnings transcript
Read the complete earnings call transcript.
CAG
Conagra Brands, Inc.
$13.49
-0.08
(-0.59%)
| Exchange: | NYSE |
| Market Cap: | 6.456B |
| Shares Outstanding: | 304.706M |
Delayed data
About The Company
| Sector: | Consumer DefensiveView sector performance | |||||
| Industry: | Packaged FoodsView industry performance | |||||
| CEO: | John Brase | |||||
| Full Time Employees: | 17400 | |||||
| Address: |
| |||||
| Website: | https://www.conagrabrands.com |
Conagra Brands, Inc., a prominent manufacturer of packaged food products, conducts its business across North America through its various subsidiary companies. The firm organizes its extensive operations into four distinct segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks division primarily distributes non-perishable food items through various retail channels within the United States. In contrast, the Refrigerated & Frozen segment focuses on supplying temperature-sensitive food products to comparable U.S. retail outlets. Its International division caters to markets outside the United States, offering food products in all temperature states to both retail consumers and professional food service operators globally. Domestically, the Foodservice segment specializes in providing both proprietary and custom-engineered culinary offerings, such as prepared meals, entrees, sauces, and other specially manufactured gastronomic items, tailored for restaurants and institutional food providers throughout the United States. Conagra maintains an extensive portfolio of well-recognized brands, including Birds Eye, Duncan Hines, Healthy Choice, Marie Callender’s, Reddi-wip, Slim Jim, Angie’s BOOMCHICKAPOP, Duke’s, Earth Balance, Gardein, and Frontera. The company, which traces its origins back to 1861, was formerly known as ConAgra Foods, Inc. until its rebranding to Conagra Brands, Inc. in November 2016. Its main corporate offices are located in Chicago, Illinois.
Click to read more…
Revenue Segmentation
CAG full analysis
Hey everyone, welcome back to MarketSnap. Conagra Brands just posted an earnings beat that sent the stock ripping higher — and yet this is a company whose shares have been cut roughly in half over the past year. So which is it: a genuine turnaround finally taking hold, or a dead-cat bounce in a business that's still bleeding? Today we're breaking down Conagra top to bottom, and we're running it through the MarketSnap valuation model with the fresh numbers to…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 12,050,900 | 11,612,800 | 11,281,600 |
| Gross Profit | 3,333,400 | 3,003,500 | 2,698,400 |
| EBITDA | 1,447,300 | 1,965,600 | -1,232,400 |
| Operating Income | 852,800 | 1,364,600 | -1,628,400 |
| Net Income | 347,200 | 1,152,400 | -1,916,200 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 20,862,300 | 20,933,900 | 17,274,400 |
| Total Liabilities | 12,351,000 | 12,001,200 | 10,916,800 |
| Total Stockholders Equity | 8,440,400 | 8,932,700 | 6,357,600 |
| Total Debt | 8,613,500 | 8,310,600 | 7,268,400 |
| Cash and Cash Equivalents | 77,700 | 68,000 | 218,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 2,015,600 | 1,691,900 | 1,402,100 |
| Capital Expenditure | -388,100 | -389,300 | -423,400 |
| Free Cash Flow | 1,627,500 | 1,302,600 | 978,700 |
| Net Income | 347,200 | 1,152,500 | -1,916,200 |
| Net Change in Cash | -16,200 | -9,700 | 150,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 10,847,571.461 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 11,192,148.969 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 10,945,110.057 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 1,706,673.897 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 1,744,379.890 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 1,717,347.178 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 742,488.321 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 773,235.331 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 751,191.751 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 1,365,579.711 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 1,408,957.905 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 1,377,858.656 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 1.570 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 1.610 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 1.550 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 8 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Defensive Sector Positioning: Operating within the Consumer Defensive sector, CAG benefits from relatively inelastic demand for its food products, providing a buffer against broader economic cyclicality compared to discretionary sectors.
- Established Dividend Profile: The company maintains a dividend yield (TTM) and a consistent history of dividend payments (netDividendsPaid), appealing to income-focused investors within the target demographic.
- Positive Free Cash Flow Generation: Despite margin pressures, the company demonstrates positive free cash flow (operatingCashFlow less capitalExpenditure), supporting its ability to fund dividends and debt obligations.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates CAG intrinsic value between $48.93 – $49.89 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about CAG valuation
Is Conagra Brands, Inc. (CAG) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for Conagra Brands, Inc. (CAG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is CAG a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CAG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is CAG’s P/E ratio?
You can see CAG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for CAG?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is CAG a good long-term investment?
Whether CAG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
CAG
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-0.59
Trading Metrics:
| Open: | 13.5 | Previous Close: | 13.57 | |
| Day Low: | 13.34 | Day High: | 13.55 | |
| Year Low: | 12.53 | Year High: | 20.32 | |
| Price Avg 50: | 15.02 | Price Avg 200: | 15.51 | |
| Volume: | 9.144M | Average Volume: | 15.77M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
